MitoChem Therapeutics
Charleston
About MitoChem Therapeutics
MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative disease. It was founded by Craig Beeson and Bärbel Rohrer in Charleston, South Carolina.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.7M
- Last round: Series Unknown (Sep 2022)
- Website: mitocheminc.com
- Phone: 520-204-5552
Industries & Categories
Biotechnology, Health Care, Life Science, Neuroscience, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/mitochem-therapeutics-36513 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.